Alkami price target lowered to $40 from $46 at Citizens JMP

Citizens JMP lowered the firm’s price target on Alkami (ALKT) to $40 from $46 and keeps an Outperform rating on the shares. Alkami reported “mixed” Q3 results and lowered its revenue guidance for the year, in part, due to some new client implementations shifting out to Q4, but increased its profitability outlook, the analyst tells investors in a research note.